Containing Or Obtained From A Leaf (aka Folium Or Foliage) Patents (Class 424/774)
  • Patent number: 7402325
    Abstract: A method for the extraction of pharmacologically active components from the oleander plant using supercritical carbon dioxide and combining the extraction with other isolation methods. The extraction is carried out using carbon dioxide at supercritical conditions, with or without the addition of a modifier. The isolated product is recovered in higher yield than with traditional hot water extraction.
    Type: Grant
    Filed: July 28, 2005
    Date of Patent: July 22, 2008
    Assignee: Phoenix Biotechnology, Inc.
    Inventor: Crandell Addington
  • Publication number: 20080152737
    Abstract: Disclosed are extracts, compositions, and methods for treating cancer and inflammatory disorders. Also disclosed are methods for preparing extracts or compounds for treating the disorders.
    Type: Application
    Filed: September 20, 2007
    Publication date: June 26, 2008
    Applicant: Academia Sinica
    Inventors: Lie-Fen Shyur, Chia-Chung Hou, Jyh-Horng Wu, Yi-Ping Chen, Sheng-Yang Wang, Chi-Chang Huang, Ning-Sun Yang
  • Patent number: 7390512
    Abstract: A Phytoceutical composition for the prevention and treatment of Multiple Sclerosis (MS) and symptoms is provided. A specific combination of extracts of plants and nutraceuticals is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects, with minimal side effects.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: June 24, 2008
    Inventor: Jose Angel Olalde Rangel
  • Patent number: 7387804
    Abstract: The present invention provides dark opal basil leaves or an extract thereof, containing anthocyanin dye derived from the dark opal basil, in concentrated form. The process of the present invention comprises steps of (1) adding salt to dark opal basil leaves, (2) dehydrating the dark opal basil leaves obtained in step (1), and (3) immersing the dark opal basil leaves obtained in step (2) in an organic acid solution. In step (2), the dark opal basil leaves to be dehydrated are physically treated to such an extent that the cells thereof are broken or not broken.
    Type: Grant
    Filed: June 2, 2003
    Date of Patent: June 17, 2008
    Assignee: Mishima Foods Co., Ltd.
    Inventors: Jun Motoyama, Kenji Baba
  • Publication number: 20080138393
    Abstract: Compositions comprising a water soluble spinach extract, compositions comprising a water soluble spinach extract, a liposome, a cardiolipin, and at least one antioxidant, compositions comprising a water soluble spinach extract, an extract of Arabidopsis thaliana or of the mustard (Brassica) plant, a liposome, a cardiolipin, and at least one antioxidant, processes for obtaining such compositions, and methods of using such compositions to repair damage to nuclear DNA, mitochondrial DNA, or both, prevent or decrease damage to such DNA from, for example, reactive oxygen species or 8-hydroxydeoxyguanosine and/or to repair or prevent mitochondrial damage and loss of membrane fluidity are disclosed. Compositions of the present invention may be topically administered, orally administered or parenterally, such as administration by injection.
    Type: Application
    Filed: January 25, 2007
    Publication date: June 12, 2008
    Inventors: Jesse C. Leverett, Rodney M. Johnson, Stephen R. Missler, David J. Fast, Tom La, John V. Scimeca
  • Publication number: 20080119544
    Abstract: The invention relates to the use of one or more cannabinolds in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from neutral antagonism of the CB, cannabinoid receptor. Preferably the cannabinoid is tetrahydrocannabivarin (THCV). Preferably the diseases and conditions to be treated are taken from the group: obesity, schizophrenia, epilepsy, cognitive disorders such as Alzheimer's, bone disorders, bulimia, obesity associated with type n diabetes (non-insulin dependant diabetes) and in the treatment of drug, alcohol and nicotine abuse or dependency.
    Type: Application
    Filed: November 15, 2005
    Publication date: May 22, 2008
    Applicant: GW PHARMA LIMITED
    Inventors: Geoffrey William Guy, Roger Pertwee
  • Publication number: 20080118591
    Abstract: The invention relates to bactericidal formulations that come into contact with human body, particularly wash formulations including liquid soaps, comprising perfume ingredients active against gram-negative bacteria. Such compositions contact the target site, for example the skin surface, only for a short time, usually not longer than 30 seconds. Therefore the antibacterial action has to be of the bactericidal type and rapid. Furthermore, the bactericidal activity has to be sufficiently high to ensure an effect even when applied to wet substrates that will dilute the bactericidal formulation.
    Type: Application
    Filed: November 15, 2005
    Publication date: May 22, 2008
    Inventor: Andreas Natsch
  • Patent number: 7374786
    Abstract: A composition for treating Xanthomonas spp. infections in agriculture crops wherein the treatment composition is an admixture of T. harzianum, Y. schidigera root extract, Y. schidigera leaf extract, and X. spp. extract. The composition is also efficacious as a pre-infection agent for enhancing the resistance of agriculture crops to such infections. The composition is preferably applied by spraying.
    Type: Grant
    Filed: January 9, 2004
    Date of Patent: May 20, 2008
    Assignee: Biosys Corporation
    Inventor: Robert M Hysmith
  • Publication number: 20080112895
    Abstract: A room temperature stable aqueous cannabinoid formulation is disclosed. In preferred embodiments, the cannabinoid formulation comprises dronabinol in a mixture of buffer solution, and organic cosolvents such as ethanol, propylene glycol and polyethylene glycol.
    Type: Application
    Filed: August 6, 2007
    Publication date: May 15, 2008
    Applicant: Insys Therapeutics Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran
  • Patent number: 7371389
    Abstract: Methods for increasing energy in men and women include ingesting internally, twice a day, products that include, for women, multivitamins, multiminerals, high-calcium bone support products, high-ORAC super food products, and enzymes, and, for men, multivitamins, multiminerals, prostate support products, high-ORAC super food products, and enzymes.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: May 13, 2008
    Assignee: Arbonne International, LLC
    Inventors: Candace R. Keefe, Michele Arth
  • Publication number: 20080102143
    Abstract: The present invention is concerned with an extract of a plant, whereby the plant belongs to the family Asclepiadaceae for use as a medicament. One embodiment of the present invention is an extract of the plant Gymnema sylvestre for use as a medicament. Said medicaments are inter alia useful for the treatment of mammalian skin (preferably human skin) that suffers from hair growth disorders. Furthermore the present invention is concerned with the use of an extract of a plant, whereby the plant belongs to the family Asclepiadaceae (especially Gymnema sylvestre) for the cosmetic treatment of human skin, whereby this treatment comprises the inhibition, suppression or retardation of hair growth.
    Type: Application
    Filed: January 7, 2005
    Publication date: May 1, 2008
    Applicant: COGNIS FRANCE S.A.S.
    Inventors: Olga Freis, Louis Danoux, Philippe Moser, Gilles Pauly
  • Patent number: 7364760
    Abstract: This invention relates to compositions for the treatment of acquired immunodeficiency diseases, especially human immunodeficiency virus (HIV), and its simian and feline counterparts (simian immunodeficiency virus (SIV), and feline immunodeficiency virus (FIV)), and to methods for their use.
    Type: Grant
    Filed: November 10, 2005
    Date of Patent: April 29, 2008
    Assignee: Chinese Herbal USA Inc.
    Inventor: Paul Y. S. Lam
  • Patent number: 7361372
    Abstract: The invention relates to an active ingredient composition used in cosmetic products, said composition containing vegetable extracts and combating in particular free radicals. The active ingredient composition is an alcohol-based mixture of vegetable extracts that is devoid of liposomes, consisting of between 0.1 and 2 wt. % green coffee-bean extract, between 0.1 and 2 wt. % Camellia sinensis leaf extract, between 0.1 and 2 wt % Pongamia pinnata extract and between 0.1 and 2 wt. % Angelica archangelica root extract and a residual content of a monovalent C2-C5 alcohol to obtain the total of 100 wt. %. The free radical protection factor amounts to 1400-2900×1014 free radicals per mg.
    Type: Grant
    Filed: May 21, 2004
    Date of Patent: April 22, 2008
    Assignee: Coty B.V.
    Inventors: Karin Golz-Berner, Leonhard Zastrow
  • Publication number: 20080069906
    Abstract: A medicament to decrease the adverse events of Orlistat, an oral lipase inhibitor, arranged to be taken in combination with Orlistat, comprising: an admixture of carminative herbs and one or more chelating agents to absorb and mechanically agitate non-digested fats.
    Type: Application
    Filed: October 24, 2006
    Publication date: March 20, 2008
    Inventor: Ronald J. Thompson
  • Patent number: 7344736
    Abstract: The invention relates to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance (BDS) for incorporation in to a medicament. It also relates to a BDS of given purity, for use in pharmaceutical formulations. In particular it relates to BDS comprising cannabinoids obtained by extraction from cannabis.
    Type: Grant
    Filed: August 14, 2002
    Date of Patent: March 18, 2008
    Assignee: GW Pharma Limited
    Inventors: Brian Whittle, Colin A. Hill, Ian R. Flockhart, David Victor Downs, Peter Gibson, Gary William Wheatley
  • Patent number: 7341745
    Abstract: A method for decreasing nicotine and other substance use in humans is disclosed. Tetrahydroberberine (THB) and its analogs, l-Tetrahydropalmatine (l-THP) and l-Stepholidine (l-SPD), are present in and can be isolated from several plants in the Magnoliidae superorder. According to the disclosed method, THB and its analogs are used to block nicotine-induced DA release, and modulate heterologous or homoeric expression of human nicotinic acetylcholine receptors (nAChR) in humans. Specifically, THB exhibits bi-directory modulation of ?4?2-nAChR-mediated currents induced by nicotine. THB also shows predominant inhibition on homologously expressed ?7-nAChR function. Thus, according to the disclosed method, THB is used to simultaneous blockade midbrain DA system function, the brain reward center, and neuronal ?4?2- and ?7-nAChR function, the major nicotine targets in the brain. Therefore, THB and its analogs serve as a novel class of natural compounds to decrease nicotine dependence in humans.
    Type: Grant
    Filed: February 7, 2003
    Date of Patent: March 11, 2008
    Assignee: Arizona Health Consulting, LLC
    Inventor: Jie Wu
  • Publication number: 20080057111
    Abstract: A herbal formulation for prevention and/or treatment of flu. The formulations comprise of plant or plant extract together with vitamins and conventional additives. The plant is isatis indigotica, or strobilanthes cusia or the mixture thereof The formulations are in the form of tablet, powder, capsule, liquid or gum. Preferably, the formulations are in the manner of effervescent or chewing gum.
    Type: Application
    Filed: August 29, 2006
    Publication date: March 6, 2008
    Inventor: Lixian Jiang
  • Patent number: 7329423
    Abstract: A thylakoid extract that is preferably stabilized and activable for treating inflammation is described. Different types of cell or tissue targets and inflammatory stimuli have been used to evaluate the performance of the extract, which, in all cases successfully modulate inflammation through a balance of pro/anti-inflammatory cytokines. Compositions comprising the extract and other anti-inflammatory agents, such as glucocorticoids or non-steroidal anti-inflammatory drugs (NSAIDs) are further disclosed and claimed.
    Type: Grant
    Filed: July 2, 2002
    Date of Patent: February 12, 2008
    Assignee: Purecell Technologies Inc.
    Inventors: Alain Andersen, Elyse Bissonnette, Rejean Drouin, Marc Purcell
  • Publication number: 20080025930
    Abstract: An anti-aging composition comprising a skin-beneficial amount of actives identified in Menyanthes trifoliata leaf, wherein the actives are inhibitors of one or more of MMP-1, 2 and 9 and/or scavengers of peroxynitrite. Also disclosed are methods of using such a composition, which include treating the skin for signs of chronological or pre-mature aging.
    Type: Application
    Filed: July 31, 2006
    Publication date: January 31, 2008
    Inventors: Hugo Corstjens, Lieve Declercq, Ilse Sente, Annelise Lobstein, Bernard Weniger, Robert Anton
  • Patent number: 7323197
    Abstract: A cigarette/tea system has a quantity of herbal plant leaves and other herbal plant parts including pulmonaria officinalia and tussilago farfara and agrimonia eupatonia and petasites hybridus and hamamelis virginiana and tropaeolum majus.
    Type: Grant
    Filed: February 10, 2006
    Date of Patent: January 29, 2008
    Inventor: Maria Lukacs
  • Publication number: 20080020027
    Abstract: Provided, among other things, is a method of treating or ameliorating an indication of mucosal or adjacent tissue comprising periodically applying to mucosa at or adjacent to disease affected tissue a rinse comprising: an effective amount of appropriate composition of herbal bioactive comprising active(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea; an antimicrobially effective amount of a quaternary ammonium surfactant; and optionally a polymer or mixture of polymers effective to coat said tissue and entrap said extract(s).
    Type: Application
    Filed: July 20, 2007
    Publication date: January 24, 2008
    Applicant: IZUN PHARMACEUTICALS CORP.
    Inventors: Zvi G. Loewy, William Zev Levine, Aron J. Saffer
  • Patent number: 7318938
    Abstract: This invention relates to a composition of the plant Withania Somnifera, and, more particularly to a high purity extract composition with advantageous levels of withanolide glycosides and oligosaccharides, a minimum of polysaccharides, and substantially low levels of free withaferin A and equivalents (withanolide aglycones), which composition provides enhanced cognition-enhancing effects for the user, and an extraction process for obtaining such composition, as well as pharmaceutical, nutritional and personal care use products thereof.
    Type: Grant
    Filed: February 26, 2004
    Date of Patent: January 15, 2008
    Assignees: Natreon, Inc., Indian Herbs Research & Supply Co., Ltd.
    Inventor: Shibnath Ghosal
  • Publication number: 20070298063
    Abstract: An gnat repellant is provided from one or more active ingredients in a oil base, that is safe and effective over long periods on herd animals and articles worn by animals. A method for repelling gnat in herd animals and treating gnat bites on herd animals is also included.
    Type: Application
    Filed: June 5, 2007
    Publication date: December 27, 2007
    Inventor: Riannon Walsh
  • Patent number: 7311931
    Abstract: The present invention is an extract of the herb Brachystemma calycinum for the amelioration or treatment of pain or discomfort due to, or associated with, osteoarthritis. The extract is obtained by a multi-step extraction process wherein the temperatures of each step never reaches boiling point.
    Type: Grant
    Filed: December 28, 2004
    Date of Patent: December 25, 2007
    Assignee: Vita Green Health Products Co., Ltd.
    Inventor: Hei Ling Helen Chan
  • Publication number: 20070281046
    Abstract: The present invention relates to the degradation and removal of organochlorine pesticides (OCP) from Chinese herb medicines. In this invention, gamma irradiation is used for the degradation and removal of OCP, such as Pentachloronitrobenzene, Aldrin, Lindane, Heptachlor, Endosulfan-1, Endosulfan-2, o,p?-DDD, p,p?-DDD, p,p?-DDE, and p,p?-DDT from Chinese herb medicines. The method of the present invention requires no chemical reagents, and the application of the method is not limited by the volume and morphology of the Chinese herb medicines.
    Type: Application
    Filed: April 24, 2007
    Publication date: December 6, 2007
    Applicant: Committee on Chinese Medicine and Pharmacy, Department of Health, Executive Yuan
    Inventors: Hsiao-Wei Wen, Fong-In Chou
  • Patent number: 7303773
    Abstract: A process for enhancing theanine extraction from plant material through a series of extraction, adsorption and filtration steps. More specifically, disclosed is a process for isolating theanine from a plant material, which includes the steps of: a) contacting the plant material with a solvent to obtain an extract comprising theanine; b) contacting the theanine extract with an adsorbent to obtain a theanine-containing eluate; and c) subjecting the theanine eluate to a filtration step to obtain a theanine-rich extract.
    Type: Grant
    Filed: October 21, 2003
    Date of Patent: December 4, 2007
    Assignee: The Procter & Gamble Company
    Inventors: Athula Ekanayake, Jianjun Justin Li
  • Patent number: 7303770
    Abstract: Vegetable sources of cancer chemoprotective agents have been identified which are extraordinarily rich in glucosinolates, metabolic precursors of isothiocyanates. The vegetable sources are used to provide a dietary means of reducing the level of carcinogens in mammals.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: December 4, 2007
    Assignee: Johns Hopkins School of Medicine
    Inventors: Jed W. Fahey, Paul Talalay
  • Patent number: 7291352
    Abstract: The present invention comprises methods and compositions comprising Areca extract compositions and compositions comprising extracts of Ilex paraguariensis or theobromine. Methods of the invention comprise methods of making pharmaceutical or nutriceutical products comprising Areca catechu extract compositions and maté extract compositions or theobromine, and methods of use of the extracted products and pharmaceutical and nutriceutical products. The present invention also comprises methods for treating conditions related to mental and physical fatigue and obesity, as well as, enhancement of mental focus, cognition, and a sense of well being, comprising administering the compositions of the present invention.
    Type: Grant
    Filed: September 20, 2004
    Date of Patent: November 6, 2007
    Assignee: HerbalScience LLC
    Inventors: Robert T. Gow, John Pierce, George W. Sypert
  • Publication number: 20070248619
    Abstract: The present invention relates to a new pharmaceutical composition from natural materials belonging in traditional Chinese medicine and to its preparation method. Said new pharmaceutical composition comprises Astragalus root, Pleurotus fungi, Winnged Euonymus Twig and Mulberry Leaf. At first, astragalus root, Pleurotus fungi, Winnged Euonymus Twig and Mulberry Leaf are extracted by water or alcohol to obtain extractive. The obtained extractive can be got by extracting the above four materials together, or by combining the extractive from the three materials together (stragalus root, Winnged Euonymus Twig and Mulberry Leaf) among above four materials with the extractive from Pleulotus fungi singly. Then the mixed extractive is centrifugalized and separated. If need be, the gained centrifugate can be made into oral formulations in various dose form with excipient by routine method. Said pharmaceutical composition has the effect of regulating immunity on the body.
    Type: Application
    Filed: June 13, 2006
    Publication date: October 25, 2007
    Inventor: Jorge P. Chang Cabezas
  • Publication number: 20070248651
    Abstract: A vitamin, mineral, herbal, and micronutrient treatment for acne via support of the physiologic processes in the body which cause acne is disclosed. It is a targeted formula, designed specifically to address the causes of acne. This specific, unique formulation preferably in a gummy substrate for ease of administration, to induce a willingness on the part of the target population to take it, and to increase the bioavailability of the active ingredients. Other types of confection or edible vehicle can be used.
    Type: Application
    Filed: July 7, 2006
    Publication date: October 25, 2007
    Inventors: Ellie Sawits, Peter C. Dea, Laura Tringale
  • Patent number: 7273627
    Abstract: Botanical compositions are described having hypoglycemic, hypolipidemic and antimicrobial activity for maintaining good health in normal person and diabetic person comprising water extract of two medicinal plants, dried leaves of Malvastrum coromandelianum and/or dried stems of Coscinium fenestratum. The extracts are used separately or in combination of fixed amount or varied amounts, as herbal beverage or in different pharmaceutical preparations.
    Type: Grant
    Filed: July 20, 2004
    Date of Patent: September 25, 2007
    Inventors: Sukanya Nimmannit, Apijade Jesadanont, Kamol Vichitpan, Somlak Poungshompoo, Sunanta Pongsamart, Ampai Panthong, Pintip Pongpech, Boonyong Tantisira, Penphun Naenna, Chaiyasit Sittiwet, Aungkana Paopadetkarn
  • Patent number: 7270839
    Abstract: This invention relates to a process by which an extract comprising integral thylakoids is obtained. The resulting extract is a potent dynamic antioxidant useful as a ROS (reactive oxygen species) scavenger. This extract is intended to be used for the treatment or prevention of diseases involving the generation of ROS, such as inflammatory diseases or cancer. This extract also finds a use as a solar screen because of its capacity to capture UV radiations and to dissipate the solar energy into heat.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: September 18, 2007
    Assignee: Purecell Technologies Inc.
    Inventor: Marc Purcell
  • Patent number: 7270838
    Abstract: The invention relates to a dietary supplement consisting of an aqueous extract of red vine leaves and an acceptable carrier which prevents and reduces the discomfort relating to mild-to-moderate chronic venous insufficiency of the legs.
    Type: Grant
    Filed: November 14, 2005
    Date of Patent: September 18, 2007
    Inventors: Anke Esperester, Hans W. Frey, Jean-Michel Vix
  • Publication number: 20070207208
    Abstract: A method of treating patients suffering from renal failure and concomitant cardiovascular disease with a low dose of the cardiac glycoside known as digoxin, and novel dosage forms to accomplish the method and to perform other uses.
    Type: Application
    Filed: February 28, 2007
    Publication date: September 6, 2007
    Inventor: Lawrence Solomon
  • Patent number: 7255884
    Abstract: A pharmaceutical preparation of Chinese herbal medicines for tonifying the kidneys and alleviating asthma is disclosed herein. The Chinese herbal medicines include Perilla Frutescens, Prunus Armeniaca, Glycyrrhiza Uralensis, Scutellaria Baicalensis, Coptis Chinesis, Tusilago Farfara, Stemona Sessilifolia, Fritillaria Cirrhosa, Pheretima Aspergillum, Psoralaea Corylifolia, Codonopsis Pilosula, Hordeum Vulgara, Massa Fermentata Medicalis, Schisandra Chinesis, and Gypsum. The preparation is used to treat thousands of patients suffering from asthma with an effective rate of 93%. The present preparation can relieve cough, expel phlegm, resist airway allergic inflammation reaction, improve pulmonary function, partial pressure of the oxygen in the blood, increase CD2, CD4, CD4/CD8, reduce IgE in blood, increase CAMP, reduce CGMP, stabilize mast cells, and inhibit the release of histamine, which make it capable of stopping an asthma attack.
    Type: Grant
    Filed: October 2, 2003
    Date of Patent: August 14, 2007
    Inventor: Hongfen Li
  • Patent number: 7247324
    Abstract: A method of using guava extract is disclosed that includes administering alcohol to a mammal, and administering guava extract within no greater than about 12 hours of administering of the alcohol. A composition is also disclosed that includes a pharmaceutically acceptable carrier and guava extract.
    Type: Grant
    Filed: August 28, 2006
    Date of Patent: July 24, 2007
    Assignee: AmerilabTechnologies, Inc.
    Inventors: Fred Wehling, Mary Aldritt, GeMing Lui
  • Publication number: 20070154573
    Abstract: A method of preparing and using a sterile non-toxic pyrogen-free cold extract from the leaves of Nerium oleander as a supplementary medication to cancer chemo-, hormon and/or radiotherapy to restore and/or ameliorate the immune system of the patient and/or to decrease side effects and increase the antitumor effects of radiotherapy and chemotherapeutics, particularly when used in combination with taxol, adriamycin, cisplatin, 5-fluoro-uracil, alimta, cyclophosphamide, mitomycin-C, navelbine, taxotere and topotecan, respectively, and its use in the manufacture of a medicament for the treatment of one or more cancers of bladder, kidney, liver, ovary, pancreas, testicle, uterus, and vagina as well as pleuramesotheliomas and Hodgkin's lymphomas.
    Type: Application
    Filed: September 20, 2006
    Publication date: July 5, 2007
    Inventors: Juay Jamil Rashan, Heinz-Herbert Fiebig, Farid Jamil Rashan
  • Patent number: 7235257
    Abstract: This invention relates to external drugs for dermal application which have a migraine-alleviating effect, in more detail ointments and patches comprising in mixing l-menthol and an essential oil into a base containing a hydrophilic high-molecular weight compound, a polyhydric alcohol and water.
    Type: Grant
    Filed: December 14, 1999
    Date of Patent: June 26, 2007
    Assignees: Rohto Pharmaceutical Co., Ltd., Teikoku Seiyaku Co., Ltd.
    Inventors: Hideakira Yokoyama, Hidetoshi Hamamoto
  • Patent number: 7229652
    Abstract: Disclosed are extracts from the leaves of Toona sinensis Roem. prepared by extracting the leaves of Toona sinensis Roem. using water and an alcohol in sequence. Also disclosed are processes for preparing extracts from the leaves of Toona sinensis Roem., and uses of such extracts in the manufacture of medicaments for use in the treatment of ovarian cancer and/or bladder cancer.
    Type: Grant
    Filed: February 23, 2004
    Date of Patent: June 12, 2007
    Assignee: Kaohsiung Medical University
    Inventors: Shyng-Shiou Yuan, Hseng-Kuang Hsu, Yi-Chen Chia
  • Patent number: 7229649
    Abstract: The invention provides methods and compositions for maintaining a state of wellness in a human by providing a dietary supplement comprising L-arginine, alone or in combination with ginseng and ginkgo biloba and/or additional nutritional supplements. The invention provides a unique blend of components that, in combination, synergistically bestow sexual wellness upon a human when taken regularly as a dietary supplement.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: June 12, 2007
    Assignee: The Daily Wellness Company
    Inventors: Hank C. K. Wuh, Aileen S. Trant
  • Patent number: 7186404
    Abstract: There is provided a photostable and synergistically enhanced topical sunscreen composition. There is further provided a method of enhancing the photostability of a sunscreen active in a topical sunscreen composition. There is further still provided a method of synergistically enhancing the UV absorbance of a sunscreen active in a topical sunscreen composition. The preferred compositions and methods of the present invention use a dibenzoylmethane sunscreen active, a Kaempferia galanga extract, and a cosmetically acceptable vehicle.
    Type: Grant
    Filed: March 29, 2005
    Date of Patent: March 6, 2007
    Assignee: Avon Products, Inc.
    Inventors: Anthony D. Gonzalez, Andrew H. Pechko, Robert E. Kalafsky
  • Patent number: 7175859
    Abstract: A composition comprising extract of one or more plants of one or more of the following plant families: Cissus, Vernonia and Brillantasia. Such compositions have beneficial activity principally in controlling weight gain and obesity, especially in conjunction with chitosan or a chitosan derivative and an antioxidant such as vitamin C.
    Type: Grant
    Filed: August 29, 2000
    Date of Patent: February 13, 2007
    Assignee: Gateway Health Alliances, Inc.
    Inventor: Julius Enyong Oben
  • Patent number: 7153877
    Abstract: A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and administering to them an effective amount of a composition comprising niacin-bound chromium that prevents or reduces the symptoms. Compositions incorporating niacin-bound chromium and additional compounds also are disclosed that are particularly effective in synergistically preventing or reducing these symptoms.
    Type: Grant
    Filed: December 9, 2004
    Date of Patent: December 26, 2006
    Assignee: Interhealth Nutraceuticals Incorporated
    Inventors: Debasis Bagchi, Harry G. Preuss, Shil C. Kothari
  • Patent number: 7132450
    Abstract: A hepatic disorder suppressant comprising extracts having hepatic disorder suppressing effect as effective ingredients, wherein the extracts is obtained by extracting an avocado plant and/or a processed product thereof with an organic solvent is disclosed.
    Type: Grant
    Filed: March 25, 2005
    Date of Patent: November 7, 2006
    Assignee: Kagome Co., Ltd.
    Inventors: Yasushi Arimoto, Hiroyuki Suganuma, Takahiro Inakuma, Kimio Sugiyama, He Puming, Hirokazu Kawagishi
  • Patent number: 7122212
    Abstract: It is intended to provide oily cosmetics (for example, oily cosmetics to be applied to the skin such as oily liniments, oily hair care products such as hair oils) which have excellent effects including an antibacterial effect and are yet safely usable by consumers sensitive to chemicals. Namely, oily cosmetics comprising oily bases such as vegetable oils, mineral oils or mixtures thereof together with tea leaf components.
    Type: Grant
    Filed: June 13, 2001
    Date of Patent: October 17, 2006
    Assignee: Pure Green Co., Ltd.
    Inventor: Masanori Kanayama
  • Patent number: 7118769
    Abstract: Described are pharmaceutical compositions containing Bulbophyllum, in particular compositions containing Bulbophyllum neilgherese, optionally in combination with suitable pharmaceutical excipients and carriers, as well as their use for treating illnesses, in particular illnesses of the cardio-vascular system.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: October 10, 2006
    Inventor: Michael Barthel
  • Patent number: 7118771
    Abstract: This invention relates to and is drawn to food compositions including waterleaf leaves harvested at full bloom. The present invention further relates to and is drawn to methods of reducing the risks of cardiovascular diseases by reducing total plasma cholesterol and plasma LDL-cholesterol and increasing plasma HDL-cholesterol and blood hematocrit using the present food compositions of waterleaf leaves, in addition to methods of preventing and treating coronary heart disease using the present food compositions.
    Type: Grant
    Filed: March 1, 2004
    Date of Patent: October 10, 2006
    Assignee: Alcorn State University
    Inventors: Michael Obi Ezekwe, Samuel Ayuk Besong, Patrick Emeka Igbokwe, Edith Ifeyinwa Ezekwe
  • Patent number: 7119110
    Abstract: A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and administering to them an effective amount of a composition comprising niacin-bound chromium that prevents or reduces the symptoms. Compositions incorporating niacin-bound chromium and additional compounds also are disclosed that are particularly effective in synergistically preventing or reducing these symptoms.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: October 10, 2006
    Assignee: Interhealth Nutraceuticals Incorporated
    Inventors: Debasis Bagchi, Harry G. Preuss, Shil C. Kothari
  • Patent number: 7112343
    Abstract: The present invention discloses an all natural composition comprising herbs for the use of restoring the immune system and subsequent medicinal value. The formulization of the present invention utilizes the benefits of herbal medicine for the use of restoring the immune system to protect and cure the body from infectious disease and various allergies. The composition formula consists of nineteen herbal ingredients in powder form that carrot powder, pau d' arco bark, gingko leaf, myrrh bark, echinacea augusta folia, slippery elm bark, heal-all-herb, celery stalk, celery leaf, red clover blooms, burdock root, goldenseal root, poke root, garlic bulb powder, beet root powder, yellow dock root, dandelion root, St. John's wort, and capscium in predetermined quantities.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: September 26, 2006
    Inventor: Robbie Shoemake
  • Patent number: 7105188
    Abstract: Therapeutic agents for skin diseases such as atopic dermatitis and athlete's foot can be obtained from naturally occurring raw materials without requiring the use of steroids and their severe adverse effects. The therapeutic agents contain a fermentation solution as the active component. The fermentation solution is obtained by fermenting raw materials including sugar components, water, and pine leaf or pine leaf clusters. The pine leaf cluster may be a fresh pine leaf cluster, from which the short shoot is preliminarily removed and then the fresh pine leaves are cut into a given length.
    Type: Grant
    Filed: August 11, 2004
    Date of Patent: September 12, 2006
    Inventor: Mitsuyo Kanda